Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 56
1982 64
1983 69
1984 85
1985 81
1986 221
1987 204
1988 202
1989 316
1990 255
1991 358
1992 349
1993 409
1994 470
1995 437
1996 610
1997 769
1998 755
1999 878
2000 828
2001 650
2002 656
2003 773
2004 573
2005 694
2006 710
2007 653
2008 535
2009 745
2010 736
2011 630
2012 734
2013 764
2014 912
2015 886
2016 953
2017 914
2018 890
2019 858
2020 844
2021 711
2022 682
2023 652
2024 97

Text availability

Article attribute

Article type

Publication date

Search Results

24,668 results

Results by year

Filters applied: . Clear all
Page 1
Retraction.
[No authors listed] [No authors listed] Anticancer Res. 2023 Oct;43(10):4780. doi: 10.21873/anticanres.16674. Anticancer Res. 2023. PMID: 37772596 No abstract available.
Corrigendum.
[No authors listed] [No authors listed] Anticancer Res. 2023 Jul;43(7):3387. doi: 10.21873/anticanres.16513. Anticancer Res. 2023. PMID: 37352009 No abstract available.
Corrigendum.
[No authors listed] [No authors listed] Anticancer Res. 2024 Jan;44(1):443. doi: 10.21873/anticanres.16831. Anticancer Res. 2024. PMID: 38160014 No abstract available.
Corrigenda.
[No authors listed] [No authors listed] Anticancer Res. 2023 Nov;43(11):5273. doi: 10.21873/anticanres.16730. Anticancer Res. 2023. PMID: 37910002 No abstract available.
Corrigendum.
[No authors listed] [No authors listed] Anticancer Res. 2024 Feb;44(2):859. doi: 10.21873/anticanres.16879. Anticancer Res. 2024. PMID: 38307594 No abstract available.
Corrigenda.
[No authors listed] [No authors listed] Anticancer Res. 2023 Sep;43(9):4255-4256. doi: 10.21873/anticanres.16619. Anticancer Res. 2023. PMID: 37648339 No abstract available.
Corrigenda.
[No authors listed] [No authors listed] Anticancer Res. 2023 Dec;43(12):5749. doi: 10.21873/anticanres.16781. Anticancer Res. 2023. PMID: 38030214 No abstract available.
Corrigenda.
[No authors listed] [No authors listed] Anticancer Res. 2023 Oct;43(10):4779. doi: 10.21873/anticanres.16673. Anticancer Res. 2023. PMID: 37772597 No abstract available.
Corrigendum.
[No authors listed] [No authors listed] Anticancer Res. 2023 May;43(5):2381. doi: 10.21873/anticanres.16405. Anticancer Res. 2023. PMID: 37097703 No abstract available.
Proteinase-activated Receptor 2: Springboard of Tumors.
Vetvicka D, Suhaj P, Olejar T, Sivak L, Benes J, Pouckova P. Vetvicka D, et al. Anticancer Res. 2024 Jan;44(1):1-12. doi: 10.21873/anticanres.16782. Anticancer Res. 2024. PMID: 38159988 Review.
24,668 results
You have reached the last available page of results. Please see the User Guide for more information.